Wealthfront’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$269K Sell
2,808
-212
-7% -$21K ﹤0.01% 461
2018
Q2
$302K Sell
3,020
-3,120
-51% -$329K ﹤0.01% 435
2018
Q1
$648K Buy
6,140
+3,135
+104% +$317K 0.01% 343
2017
Q4
$278K Sell
3,005
-77
-2% -$7K ﹤0.01% 441
2017
Q3
$279K Sell
3,082
-56
-2% -$4.77K ﹤0.01% 434
2017
Q2
$264K Buy
3,138
+459
+17% +$37K ﹤0.01% 399
2017
Q1
$216K Buy
+2,679
New +$211K ﹤0.01% 405
2015
Q4
Sell
-921
Closed -$60K 502
2015
Q3
$60K Sell
921
-688
-43% -$50.8K ﹤0.01% 493
2015
Q2
$132K Buy
1,609
+1,118
+228% +$86.2K 0.01% 352
2015
Q1
$34K Sell
491
-243
-33% -$17.5K ﹤0.01% 507
2014
Q4
$56K Buy
734
+286
+64% +$22.6K ﹤0.01% 463
2014
Q3
$36K Sell
448
-102
-19% -$8.51K ﹤0.01% 462
2014
Q2
$49K Buy
550
+222
+68% +$19.3K ﹤0.01% 370
2014
Q1
$28K Buy
+328
New +$26.9K ﹤0.01% 377

Other funds holding EMN

Wealthfront's EMN Position: Q3 2018 in Review

Wealthfront reduced its Eastman Chemical (EMN) stake by 7% in Q3 2018, selling an estimated $21K and leaving 2,808 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Wealthfront first reported a position in EMN in Q1 2014 and has held it in 14 quarters since. The position peaked at $648K in Q1 2018. 698 funds tracked by Wall St. Rank hold EMN as of Q3 2018.

  • Wealthfront held 2,808 shares of Eastman Chemical worth $269K as of Q3 2018.
  • Wealthfront sold 212 Eastman Chemical shares in Q3 2018, an estimated $21K.
  • Eastman Chemical made up ﹤0.01% of Wealthfront's portfolio in Q3 2018, its #461 holding.
  • Wealthfront first reported a position in Eastman Chemical in Q1 2014 and has held it in 14 quarters since.
  • Wealthfront's Eastman Chemical position peaked at $648K in Q1 2018.
  • 698 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.